Specific recognition of t(6;9)-positive leukemia cells by DEK-CAN fusion peptide-specific CD4+ T lymphocytes in an HLA-DR-restricted manner.

被引：0
|
作者：
Makita, M
Azuma, T
Hamaguchi, H
Fujita, S
Tanimoto, M
Harada, M
Yasukawa, M
机构：
[1] Ehime Univ, Sch Med, Dept Internal Med 1, Shigenobu, Ehime 79102, Japan
[2] Musashino Red Cross Hosp, Dept Hematol, Musashino, Tokyo, Japan
[3] Okayama Univ, Grad Sch Med, Dept Biopathol Sci, Okayama, Japan
[4] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosystem Sci, Fukuoka, Japan
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
506
引用
收藏
页码：121A / 121A
页数：1
相关论文
共 50 条
  • [41] Selective ex vivo expansion of cytomegalovirus-specific CD4+ and CD8+ T lymphocytes using dendritic cells pulsed with a human leucocyte antigen A*0201-restricted peptide
    Vannucchi, AM
    Glinz, S
    Bosi, A
    Caporale, R
    Rossi-Ferrini, P
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) : 479 - 482
  • [42] Analysis of the Conservation of T Cell Receptor Alpha and Beta Chain Variable Regions Gene in pp65 Peptide-Specific HLA-A~*0201-Restricted CD8~+ T Cells
    Wei Luo1
    2School of Biosciences & Bioengineering
    Cellular & Molecular Immunology, 2009, 6 (02) : 105 - 110
  • [43] Analysis of the Conservation of T Cell Receptor Alpha and Beta Chain Variable Regions Gene in pp65 Peptide-Specific HLA-A*0201-Restricted CD8+ T Cells
    Wei Luo
    Li Ma
    Qian Wen
    Mingqian Zhou
    Xiaoning Wang
    Cellular & Molecular Immunology, 2009, 6 : 105 - 110
  • [44] The abl/bcr gene product as a novel leukemia-specific antigen: peptides spanning the fusion region of abl/bcr can be recognized by both CD4+ and CD8+ T lymphocytes
    Wolfgang M. Wagner
    Qin Ouyang
    Graham Pawelec
    Cancer Immunology, Immunotherapy, 2003, 52 : 89 - 96
  • [45] The abl/bcr gene product as a novel leukemia-specific antigen:: peptides spanning the fusion region of abl/bcr can be recognized by both CD4+ and CD8+ T lymphocytes
    Wagner, WM
    Ouyang, Q
    Pawelec, G
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (02) : 89 - 96
  • [46] ABSENCE OF EPSTEIN-BARR VIRUS-SPECIFIC, HLA CLASS-II-RESTRICTED CD4+ CYTOTOXIC LYMPHOCYTES-T IN INFECTIOUS-MONONUCLEOSIS
    ENSSLE, KH
    FLEISCHER, B
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1990, 79 (03): : 409 - 415
  • [47] Comprehensive analysis of HLA-DR- and HLA-DP4-restricted CD4+ T cell response specific for the tumor-shared antigen survivin in healthy donors and cancer patients
    Wang, Xiao-Fei
    Kerzerho, Jerome
    Adotevi, Olivier
    Nuyttens, Helene
    Badoual, Cecile
    Munier, Gaetan
    Oudard, Stephane
    Tu, Shuiping
    Tartour, Eric
    Maillere, Bernard
    JOURNAL OF IMMUNOLOGY, 2008, 181 (01): : 431 - 439
  • [48] Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells
    Wang, HY
    Peng, GY
    Guo, Z
    Shevach, EM
    Wang, RF
    JOURNAL OF IMMUNOLOGY, 2005, 174 (05): : 2661 - 2670
  • [49] Wilms tumor protein-1-derived 9-mer peptide induces CD4 T-cell responses in an HLA-DR restricted manner
    Fuji, S.
    Fischer, J.
    Kapp, M.
    Stevanovic, S.
    Bumm, T.
    Rammensee, H. G.
    Einsele, H.
    Huenig, T.
    Grigoleit, G. U.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S159 - S159
  • [50] Wilms Tumor Protein-1-Derived 9-Mer Peptide Induces CD4 T-Cell Responses in an HLA-DR Restricted Manner
    Fuji, Shigeo
    Fischer, Julia
    Kapp, Markus
    Bumm, Thomas G.
    Einsele, Hermann
    Stevanovic, Stefan
    Rammensee, Hans-Georg
    Hunig, Thomas
    Grigoleit, Goetz Ulrich
    BLOOD, 2012, 120 (21)
12345